Zcchc10-flox Mouse

Zcchc10, zinc finger CCHC-type containing 10, has emerged as a significant gene with implications in multiple biological processes and disease conditions. It is involved in regulating important cellular functions, such as influencing tumor-related pathways. Its potential as a tumor suppressor has been highlighted, and it may play a role in pathways like p53-related signaling, telomerase regulation, and NF-κB activation [1,3,4].

In lung adenocarcinoma, Zcchc10 expression is lower in cancer tissues compared to adjacent non-cancerous tissues, and decreased Zcchc10 mRNA predicts poorer patient survival. Ectopic expression of Zcchc10 in wild-type p53-harboring lung cancer cells suppresses cell proliferation, colony formation, migration, invasion, cisplatin resistance in vitro, and tumor growth and metastasis in vivo. Knockdown in normal lung cells has opposite effects. Mechanistically, Zcchc10 binds and stabilizes p53 by disrupting the p53-MDM2 interaction [1].

In acute myeloid leukemia (AML), Zcchc10 expression is downregulated in patient bone marrow samples. The lncRNA SNHG1 promotes Zcchc10 promoter hypermethylation, leading to its epigenetic silencing. Overexpression of Zcchc10 in AML cells increases p53 expression, suppresses cell proliferation and survival, and improves sensitivity to venetoclax in a xenograft mouse model [2].

In melanoma, Zcchc10 and PITX1 cooperate to inhibit hTERT transcription, with Zcchc10 expression decreased in most melanoma cell lines and tissues [3].

In colorectal cancer, miR-410-3p targets Zcchc10, and knockdown of Zcchc10 activates the NF-κB pathway, promoting epithelial-mesenchymal transition, cell migration, and invasion [4].

In conclusion, Zcchc10 appears to have a tumor-suppressive role, mainly through stabilizing p53 protein in lung cancer and AML, and by regulating hTERT transcription in melanoma. In colorectal cancer, its regulation by miR-410-3p affects cell migration and invasion via the NF-κB pathway. These findings from in vitro and in vivo studies highlight Zcchc10 as a potential prognostic marker and therapeutic target in these malignancies [1,2,3,4].